@cdheer.bsky.social
But the free market is so efficient! 🙄
The greedy psychopaths!
Goldman Sachs: cures could be bad for business in the long run.
“Is curing patients a sustainable business model?” GS analysts ask in an April 10 report entitled “The Genome Revolution.”
www.cnbc.com/2018/04/11/g...
Goldman Sachs asks in biotech research report: 'Is curing patients a sustainable business model?'
Goldman Sachs warns sales from the most successful disease treatments are difficult to maintain.
www.cnbc.com
January 3, 2025 at 11:59 PM
But the free market is so efficient! 🙄